Alerts will be sent to your verified email
Verify Email
SAROJA
|
Saroja Pharma Ind
|
Venmax Drugs&Pharma
|
Norris Medicines
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
33.33 % | -44.32 % | 47.03 % |
|
5yr average Equity Multiplier
|
4.66 | -0.19 | -2.46 |
|
5yr Average Asset Turnover Ratio
|
2.98 | 0.32 | 0.6 |
|
5yr Avg Net Profit Margin
|
2.08 % | -30.94 % | -30.66 % |
|
Price to Book
|
0.0 | 4.33 | 0.0 |
|
P/E
|
17.54 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
80.28 Days | 0.0 | 97.28 Days |
|
Inventory Days
|
11.27 Days | 24.83 Days | 165.43 Days |
|
Days Receivable
|
122.72 Days | 0.0 | 69.98 Days |
|
Days Payable
|
47.62 Days | 189.56 Days | 260.51 Days |
|
5yr Average Interest Coverage Ratio
|
2.76 | -318.36 | -1.37 |
|
5yr Avg ROCE
|
37.65 % | -45.33 % | -19.87 % |
|
5yr Avg Operating Profit Margin
|
4.76 % | -50.41 % | -6.94 % |
|
5 yr average Debt to Equity
|
1.78 | -0.64 | -3.0 |
|
5yr CAGR Net Profit
|
3.81 % | n/a | -15.97 % |
|
5yr Average Return on Assets
|
6.13 % | 187.49 % | -18.92 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.02 % | 23.13 % | 34.0 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -0.04 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Saroja Pharma Ind
|
Venmax Drugs&Pharma
|
Norris Medicines
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|